Standard Biotools | FLDM - Pre Tax Profit


Standard Biotools reported $-14.62M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Agilent USD 364M 78M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
Bruker USD 68.2M 140.8M Dec/2025
Danaher USD 1.24B 138M Mar/2026
Illumina USD 157M 220M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Nikon Corporation JPY -96.59B 90.53B Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sony JPY 123.8B 376.41B Mar/2026
Standard Biotools USD -14.62M 7.42M Mar/2026
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Waters USD 264.18M 94.06M Dec/2025